Yes, while a new person signals a fresh start, ACR will still be themselves and the market place for the medicines will not have changed and the FDA is in disarray. To use a Titanic analogy, we are at the point where the iceberg is in sight and the ship is still powering straight towards it, with all boilers blazing and the rudder is too small to turn.
What is remarkable is why anyone would have taken this job. In some ways it makes you hope. I mean why would anyone take command at this juncture if they didn’t have some thoughts on what to do. I mean the new commander will just get on to the bridge as the iceberg looms larger - and the orders will be?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.548M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 950151 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 135678 | 3 |
View Market Depth
| Last trade - 09.59am 18/07/2025 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable